Psyched Wellness Completes Extraction Protocol For First Mushroom Products

Psyched Wellness (CSE: PSYC) has completed a number of milestones with regards to getting its first amanita muscaria mushroom products to market. The company announced this morning that it has completed lab experiments that are comprehensive in nature for the final extraction protocol for the amanita muscaria mushroom.

The protocol for extraction will then be used to enable the company to get the first line of products to market. The material safety data sheet for its amanita muscaria extract has also been completed, along with assembly of safety and efficacy narratives.

The completion of the extraction protocol will essentially allow for the company to expand operations in terms of production, while also enabling a higher yield and capacity of the psychoactive compound found within the Amanita Muscaria mushroom, known as Muscimol.

“With the completion of the final extraction process and finalizing the SDS, we are now able to start producing larger-scale extraction and ship it abroad. The team is doing a great job and I am confident we will be able to start our pre-clinical trials with our CRO partner in Asia before year ends.”

David Shisel, Chief Operating Officer of Psyched Wellness

The announcement of a completed extraction protocol follows the news earlier this week that Psyched has completed its toxicology assessment on the Amanita Muscaria mushroom. The results, which were positive in nature, have enabled the firm to move ahead with establishing a path to market for its products. The company is working towards submitted to the US FDA and Health Canada for classification as a new dietary ingredient and a natural health product, respectively.

Altamira Gold Corp. — sponsored Sponsored · Altamira Gold Corp.

Psyched Wellness last traded at $0.25 on the CSE.


FULL DISCLOSURE: Psyched Wellness is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Psyched Wellness on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Everybody Should Own Gold | George Bee – U.S. Gold Corp.

A $40M Company Created $2B in Mining Value | John-Mark Staude – Riverside Resources

The Debt Crisis Is Turning Gold Into Money | Shawn Khunkhun – Contango Silver and Gold

Recommended

Epic Gold Assays 9.42 g/t Gold Over 11 Metres at Hawkins In Trenching, Links Occurrences Along 15 Kilometre Corridor

Goliath Cuts 28.81 g/t Gold Equivalent Over 4 Metres Within Broader Surebet Intercept

Related News

Psyched Wellness Moves To Next Stage Of Pre-Clinical Trials With Mushroom Extract

Psyched Wellness (CSE: PSYC) continues to execute on its strategy as it pertains to the...

Thursday, October 7, 2021, 08:21:06 AM

Psyched Wellness Announces Study On Muscimol Antioxidant and Anti-Inflammatory Properties

Psyched Wellness (CSE: PSYC) has begun yet another study related to that of the Amanita...

Wednesday, January 6, 2021, 07:48:08 AM

Psyched Wellness To Conduct Stability Tests On Proprietary Mushroom Extract

Psyched Wellness (CSE: PSYC) is progressing with the development of its flagship product, an extract...

Monday, July 26, 2021, 09:28:00 AM

Psyched Wellness Launches Study On Mushroom Extract Focused On Gut Health

Psyched Wellness (CSE: PSYC) this morning issued a very brief press release related to ongoing...

Tuesday, March 30, 2021, 08:31:58 AM

David Nutt: Amanita Muscaria Due For More Research – The Daily Dive

Today on the Daily Dive, our host Cassandra Leah sits down with Dr David Nutt,...

Wednesday, March 10, 2021, 01:30:00 PM